Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 10 studies | 27% ± 10% | |
oligodendrocyte precursor cell | 6 studies | 29% ± 9% | |
astrocyte | 5 studies | 23% ± 3% | |
glutamatergic neuron | 4 studies | 42% ± 16% | |
endothelial cell of lymphatic vessel | 4 studies | 26% ± 7% | |
GABAergic neuron | 4 studies | 42% ± 14% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 40% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 7534.82 | 245 / 245 | 99% | 82.86 | 498 / 502 |
brain | 99% | 3705.56 | 2616 / 2642 | 99% | 76.98 | 701 / 705 |
liver | 100% | 6601.98 | 226 / 226 | 97% | 55.26 | 392 / 406 |
pancreas | 100% | 11692.56 | 328 / 328 | 92% | 42.09 | 163 / 178 |
thymus | 100% | 7073.98 | 653 / 653 | 91% | 32.55 | 552 / 605 |
adrenal gland | 98% | 3590.29 | 252 / 258 | 93% | 83.70 | 213 / 230 |
kidney | 98% | 2401.92 | 87 / 89 | 76% | 19.62 | 687 / 901 |
breast | 100% | 3829.48 | 459 / 459 | 67% | 17.25 | 749 / 1118 |
lung | 99% | 3664.00 | 575 / 578 | 58% | 12.57 | 669 / 1155 |
intestine | 95% | 3109.07 | 919 / 966 | 49% | 9.99 | 260 / 527 |
stomach | 99% | 3164.91 | 357 / 359 | 43% | 8.01 | 123 / 286 |
uterus | 98% | 4462.44 | 167 / 170 | 42% | 13.35 | 192 / 459 |
bladder | 100% | 2063.62 | 21 / 21 | 31% | 6.37 | 158 / 504 |
skin | 70% | 1297.88 | 1273 / 1809 | 55% | 18.04 | 258 / 472 |
ovary | 94% | 2850.13 | 170 / 180 | 21% | 3.91 | 90 / 430 |
esophagus | 82% | 2071.06 | 1185 / 1445 | 27% | 4.37 | 50 / 183 |
eye | 0% | 0 | 0 / 0 | 100% | 68.41 | 80 / 80 |
spleen | 100% | 6033.66 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 99% | 2793.09 | 1191 / 1204 | 0% | 0 | 0 / 0 |
heart | 98% | 2049.69 | 846 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 53% | 802.22 | 710 / 1335 | 0% | 0 | 0 / 0 |
muscle | 32% | 303.74 | 253 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 11% | 1.58 | 5 / 45 |
peripheral blood | 0% | 1.45 | 2 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0007169 | Biological process | cell surface receptor protein tyrosine kinase signaling pathway |
GO_0005575 | Cellular component | cellular_component |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0005515 | Molecular function | protein binding |
GO_0030971 | Molecular function | receptor tyrosine kinase binding |
Gene name | SHC2 |
Protein name | SHC adaptor protein 2 SHC-transforming protein 2 (Protein Sck) (SHC-transforming protein B) (Src homology 2 domain-containing-transforming protein C2) (SH2 domain protein C2) |
Synonyms | SCK SHCB |
Description | FUNCTION: Signaling adapter that couples activated growth factor receptors to signaling pathway in neurons. Involved in the signal transduction pathways of neurotrophin-activated Trk receptors in cortical neurons (By similarity). . |
Accessions | K7ENB2 ENST00000590222.5 ENST00000590170.3 ENST00000264554.11 K7EKS8 P98077 |